We help clients assess chemical compound safety to develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products. At the frontline of next generation risk assessment (NGRA), we develop customized cell-based assays to determine safety, model chemical disposition in the body, and analyze and interpret genetic data. Our solutions save our clients time and money by bringing their products to market faster.
Latest News (See all)
One of the premier thought leaders in the area of physiologically based pharmacokinetic modeling (PBPK), Dr. Fisher’s research interests have focused on the development and application of pharmacokinetic and biologically based mathematical models to ascertain health risks from environmental, food-borne and occupational chemical exposures.
Join ScitoVation’s Director of Computational Toxicology, Patrick McMullen, at this joint webinar on Dec. 8 at 1pm EST as he and panelists from Gradient and Praedicat explore tools and strategies for identifying… Read more »
ScitoVation and BioSpyder are excited to introduce our new transcriptomics analysis package, ScitoXpress™. ScitoXpress™ provides important information about points of departure (POD) and potential modes of action (MoA) for our clients’ compounds. ScitoXpress™ characterizes chemical risk cost-efficiently and rapidly.
Because changes in gene expression precede changes in phenotype, a robust transcriptomics package like ScitoXpress™ can provide answers at lower doses compared to disease or tumor endpoints are typical used in in vivo studies. ScitoXpress™ offers the additional advantages of:
- Providing utility in guiding additional studies, resulting in cost- and time-savings
- Being based on a rigorous scientific approach, applied by experts
- Having the support of U.S. EPA
Learn more about ScitoXpress™ during our webinar on Thursday, April 4th. We look forward to sharing more with you!
Who We Serve
By combining modern biological and computational methods, we help our clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals and consumer products.
Using Physiologically Based Pharmacokinetic (PBPK) Modeling and In vitro to In vivo Extrapolation (IVIVE) in Risk Assessment
To kick off a new year and decade, we assessed ScitoVation’s current and prospective positioning in the risk assessment community. As part of that process, the leadership team reviewed our… Read more »
By Mel Andersen, Ph.D., Senior Program Advisor It’s a grand time to be a toxicologist committed to using non-animal based biological and computational methods to assess the safety of chemicals and chemical products for human populations. My toxicology career… Read more »